Regulatory Actions
FDA Should Ban High Mercury Tuna From U.S. Market, as Canada Requires, According to Advocates
Published in FDA Law Weekly, March 22nd, 2007
"FDA's own testing indicates that some albacore canned tuna has very high mercury levels comparable to those found in Canada," said Michael Bender, director of the Mercury Policy Project. "However, the agency has done nothing to prevent high mercury tuna from ending up in our children's sandwiches or our dinner plates."
A recent national news report in Canada indicated that 8 out of 60 cans of albacore tuna exceeded the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2007-03-22)
More Articles from FDA Law Weekly
- Drug Safety
Taking the wraps off drug safety data from clinical trials - Heart Attack
N.J. VIOXX Product Liability Trial Proceeds to Second Phase - Patents
FDA Grants Pediatric Exclusivity For RISPERDAL (Risperidone) - Patents
LifeCycle Pharma Announces Approval of its LCP-FenoChol Product Will not be Subject to a So-Called 30-Month Stay Under the Hatch-Waxman Act - Regulatory Actions
Clubs warned that ban on gas is no laughing matter - Adverse Drug Reactions
Research in the area of adverse drug reactions reported from Linkoping University, Division of Clinical Pharmacology - More from this issue of FDA Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
